Company intelligence / Profile preview

Artialis

Liège, Liège Province, Belgiumartialis.com ↗

Ownership: Private
Development stage: Other

Overview

Artialis provides end-to-end R&D services—including biotesting, preclinical models, clinical trials, regulatory support—for companies developing therapeutics or products in musculoskeletal health and healthy aging. They have completed over ~150 projects with expertise in biomarker development/validation. Originally spun out from the University of Liege’s Bone & Cartilage Research Unit in Belgium in October 2010 to commercialize osteoarthritis biomarkers. Now they offer comprehensive CRO/CRDO services across Europe with global reach.

Therapeutic areas: Metabolic DisordersEndocrinologyImmunologyRheumatologyGastroenterology
Modalities: Biomarkers-based immunoassaysAdvanced Therapy Medicinal Products (ATMPs)Small moleculesbiologicsmedical devicesfood supplements
Industry: Contract Research Organization

Beyond the preview

Go deeper on Artialis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artialis.

Explore the full profile